Advertisement

SOUTH SAN FRANCISCO, Calif. (AP) — Drug developer Theravance Inc. says it has completed a public offering of 8.6 million shares, for net proceeds of approximately $93.6 million.

The company did not say how it plans to use the money.

In trading for the day, shares rose fell 2 cents to $12.70. Shares have ranged between $9.62 and $18.56 over the past 52 weeks.

Advertisement
Advertisement